Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/12/2025 | 14.03 M | $470.61 M | 57.16% | 15.07% |
| VANGUARD GROUP INC | 05/09/2025 | 9.31 M | $312.31 M | 2.44% | 10.00% |
| BLACKROCK, INC. | 05/02/2025 | 7.66 M | $256.80 M | 1.88% | 8.22% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 6.89 M | $231.14 M | -0.85% | 7.40% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 6.24 M | $209.29 M | 1.61% | 6.70% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 5.11 M | $171.47 M | -5.58% | 5.49% |
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2025 | 4.61 M | $154.45 M | 13.01% | 4.95% |
| ECOR1 CAPITAL, LLC | 05/15/2025 | 4.29 M | $143.82 B | 0.00% | 4.61% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 3.42 M | $118.90 M | 22.50% | 3.68% |
| STATE STREET CORP | 05/15/2025 | 3.28 M | $110.12 M | 9.78% | 3.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.19 M | $73.50 M | 4.39% | 2.35% |
| JENNISON ASSOCIATES LLC | 05/05/2025 | 2.12 M | $71.10 M | -21.73% | 2.28% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 1.95 M | $65.27 M | 1.85% | 2.09% |
| SIREN, L.L.C. | 05/23/2025 | 1.69 M | $56.64 M | 4.91% | 1.81% |
| VESTAL POINT CAPITAL, LP | 05/15/2025 | 1.50 M | $50.31 M | 100.00% | 1.61% |
| NOVO HOLDINGS A/S | 05/15/2025 | 1.28 M | $42.76 M | 32.78% | 1.37% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.05 M | $35.12 M | 23.46% | 1.12% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 999.00 K | $33.51 M | 0.00% | 1.07% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 963.28 K | $32.31 M | -39.48% | 1.03% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/05/2025 | 920.02 K | $30.86 M | 35.47% | 0.99% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2025 | 872.64 K | $29.27 M | 2.49% | 0.94% |
| NORTHERN TRUST CORP | 05/13/2025 | 857.08 K | $28.75 M | -2.58% | 0.92% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2025 | 855.42 K | $28.69 M | -3.39% | 0.92% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 778.40 K | $26.11 M | -72.09% | 0.84% |
| FISHER ASSET MANAGEMENT, LLC | 05/14/2025 | 773.35 K | $25.94 M | 38.27% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 753.53 K | $25.27 M | -0.74% | 0.81% |
| AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 719.58 K | $24.13 M | 50.76% | 0.77% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 689.27 K | $23.12 M | -31.27% | 0.74% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 631.96 K | $21.20 M | 2.42% | 0.68% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 610.84 K | $20.49 M | 6.04% | 0.66% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 600.00 K | $20.12 M | -40.00% | 0.64% |
| 05/12/2025 | 562.94 K | $15.86 M | 100.00% | 0.60% | |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 523.43 K | $17.56 M | 1.36% | 0.56% |
| SG AMERICAS SECURITIES, LLC | 04/15/2025 | 522.27 K | $17.52 M | -3.72% | 0.56% |
| ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 514.81 K | $17.27 M | 2.41% | 0.55% |
| MORGAN STANLEY | 05/15/2025 | 514.68 K | $17.26 M | 1.91% | 0.55% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 499.59 K | $16.76 M | -30.73% | 0.54% |
| CANDRIAM S.C.A. | 05/14/2025 | 488.91 K | $16.40 M | 100.00% | 0.53% |
| FIERA CAPITAL CORP | 05/07/2025 | 438.34 K | $14.70 M | -3.66% | 0.47% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 429.06 K | $14.39 M | 95.45% | 0.46% |
| VOYA INVESTMENT MANAGEMENT LLC | 05/15/2025 | 358.54 K | $12.03 M | -7.88% | 0.39% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 350.00 K | $11.74 B | 100.00% | 0.38% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 347.58 K | $11.66 M | 6.86% | 0.37% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 344.58 K | $11.56 M | -0.05% | 0.37% |
| 05/06/2025 | 342.73 K | $11.50 M | 2.38% | 0.37% | |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 304.93 K | $10.23 M | 29.60% | 0.33% |
| M&G PLC | 05/13/2025 | 281.82 K | $9.58 M | 100.00% | 0.30% |
| JPMORGAN CHASE & CO | 05/12/2025 | 265.50 K | $8.90 M | -1.50% | 0.29% |
| VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 251.33 K | $8.43 M | -10.70% | 0.27% |
| PRUDENTIAL FINANCIAL INC | 05/13/2025 | 242.88 K | $8.28 M | -12.44% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Crinetics Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 294 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FMR LLC: 14.03 M
VANGUARD GROUP INC: 9.31 M
BlackRock, Inc.: 7.66 M
WELLINGTON MANAGEMENT GROUP LLP: 6.89 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 6.24 M
PRICE T ROWE ASSOCIATES INC /MD/: 5.11 M
109.43% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 108.13 M shares in the last 24 months. This purchase volume represents approximately $3.20 B in transactions.